Cardiovascular disease is projected to remain the single leading cause of death over the next two decades, accountable for considerable disability and reduction in the quality of life, therefore
Our aim is to better understand the mechanisms of cardiovascular and metabolic diseases affecting people with the conditions covered by our clinical specialities (i.e. diabetes, renal disease,